Home

Aurobindo Pharma Limited

NSE: AUROPHARMA

₹1,785.00
+4.69%
EOD snapshot

About Aurobindo Pharma Limited

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Healthcare · Drug Manufacturers - Specialty & Generic

Full scanner analysis & price chartMembers

Results

No scheduled results found for AUROPHARMA.

Historical quarterly results aren't available in the current data feed.

Corporate Actions

No recent corporate actions for AUROPHARMA.

Latest News · Aurobindo Pharma Limited

Loading news…

More in Healthcare

All companies, by sector

Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.